Trakya University

About: Trakya University is a education organization based out in Edirne, Turkey. It is known for research contribution in the topics: Population & Medicine. The organization has 2727 authors who have published 5490 publications receiving 76048 citations. The organization is also known as: University of Thrace & Trakya Üniversitesi.

Exploring the influence of the patterns of mobile internet use on university students’ nomophobia levels

Abstract: The purpose of this study is to examine the supposed effects of the duration of the mobile internet ownership in terms of years, the duration of daily mobile internet use and monthly mobile internet quota variables on the nomophobia levels of University students. The study group consists of a total of 645 students, of whom are 429 female and 216 male, who are studying in different departments and come from different age groups. The Nomophobia Scale (NMP-Q) was used to determine the effect of variables on the nomophobia of university students. One-way ANOVA, simple and multiple regression analysis technique were used in the analysis of the data. Findings of the study showed that there was no significant difference between the duration of smartphone ownership and the level of nomophobia among college students, whereas the level of nomophobia was higher among the students who check the smartphone more frequently than during the day. Furthermore, according to the results of multiple regression analysis, variables such as duration of mobile internet ownership in terms of years, duration of daily mobile internet use and GSM mobile internet quota are predictive of the nomophobia prevalence of university students. Among these three variables, it is determined that the most predictive level of nomophobia is the daily mobile internet use. Article visualizations:

The Evaluation of the Reliability of Periotest for Implant Stability Measurements: An In Vitro Study

Abstract: Periotest (Medizintechnik Gulden, Modautal, Germany) is a widely accepted implant stability measurement method, although the reliability is not well known. The aim of this in vitro study was to inv...

Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.

Abstract: PURPOSE: To describe the outcome of intraluminal high-dose-rate (HDR) brachytherapy with metallic stenting in patients with obstructing extrahepatic cholangiocarcinoma. MATERIALS AND METHODS: Eight patients with inoperable and/or unresectable extrahepatic bile duct carcinomas were treated with intraluminal brachytherapy (ILBT) followed by self-expandable metallic stent placement. Following percutaneous transhepatic drainage, ILBT was delivered by an HDR-Ir-192 source using the Micro-Selectron afterloading device. Two treatments were planned one week apart, with each treatment consisting of a single 10 Gy fraction. Biliary patency and palliative effect were assessed by serial labs (including bilirubin/alkaline phosphatase), symptomatic improvement, and/or cholangiography. RESULTS: All eight patients tolerated the first application of ILBT well, and five of them completed two-intraluminal treatments. Six of eight had satisfactory control of jaundice until death. Pain relief was observed in four of five (80%) and pruritus in six of seven (86%) patients experiencing such symptoms. The mean and median times of stent patency were 6.9 and 5 months (range, 4-14), respectively. Gastrointestinal bleeding and/or cholangitis occurred in three patients. CONCLUSION: HDR ILBT with metallic stenting for patients with obstructive jaundice from extrahepatic bile duct carcinoma appears to be feasible and associated with acceptable toxicity. These treatments may lead to an improved quality of life in these patients.

The effect of dexmedetomidine on liver histopathology in a rat sepsis model: an experimental pilot study.

Abstract: BACKGROUND In this pilot study, we aimed to investigate the effect of dexmedetomidine on liver tissues during experimental sepsis by histopathological examination. METHODS The animals were allocated randomly to four groups, two of which received endotoxin. In the Sepsis Group (n:10) and Dexmedetomidine/Sepsis Group (n:10), endotoxemia was induced by E. coli lipopolysaccharide derived from E. coli 0111: B4. Animals in the Control Group (n:10) received an infusion of 0.9% saline (1.0 mL x kg(-1) x hr(-1)) intravenously. The Dexmedetomidine Group (n:10) and Dexmedetomidine/Sepsis Group received a bolus injection of 0.9% saline (1.0 mL/kg), followed by dexmedetomidine administration (infusion at 5 microg x kg(-1) x hr(-1)). All rats were euthanized at the 8th hour of endotoxin infusion. Histopathological examinations were performed on liver tissues. RESULTS In the liver, central venous congestion, congestion and dilation of the hepatic sinusoids and inflammation of the portal tracts were noted in the Sepsis Group. These parameters were seen slightly in the Sepsis/Dexmedetomidine group. There was a statistically significant difference between the Sepsis and Sepsis/Dexmedetomidine Groups (p<0.001). CONCLUSION Dexmedetomidine has a protective effect on liver tissues during experimental sepsis in the rat. We propose that dexmedetomidine sedation may be useful in the therapy of the liver dysfunction associated with sepsis and in other diseases related to local or systemic inflammation.